BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 29857931)

  • 21. Complement defense mechanisms.
    Tomlinson S
    Curr Opin Immunol; 1993 Feb; 5(1):83-9. PubMed ID: 8452679
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The role of complement in neonatal hypoxic-ischemic cerebral injury.
    Lassiter HA
    Clin Perinatol; 2004 Mar; 31(1):117-27. PubMed ID: 15183661
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Complement as a Biological Tool to Control Tumor Growth.
    Macor P; Capolla S; Tedesco F
    Front Immunol; 2018; 9():2203. PubMed ID: 30319647
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Complement and complement receptors.
    Ross GD
    Curr Opin Immunol; 1989 Oct; 2(1):50-62. PubMed ID: 2692625
    [No Abstract]   [Full Text] [Related]  

  • 25. Role of Complement on Broken Surfaces After Trauma.
    Huber-Lang M; Ignatius A; Brenner RE
    Adv Exp Med Biol; 2015; 865():43-55. PubMed ID: 26306442
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Immune evasion of tumor cells using membrane-bound complement regulatory proteins.
    Gorter A; Meri S
    Immunol Today; 1999 Dec; 20(12):576-82. PubMed ID: 10562709
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Opsonic and nonopsonic interactions of C3 with Streptococcus pneumoniae.
    Hostetter MK
    Microb Drug Resist; 1999; 5(2):85-9. PubMed ID: 10432269
    [No Abstract]   [Full Text] [Related]  

  • 28. Opsonin-dependent and independent surface phagocytosis of S. aureus proceeds independently of complement and complement receptors.
    Gordon DL; Rice JL
    Immunology; 1988 Aug; 64(4):709-14. PubMed ID: 2971611
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Complement: an efficient sword of innate immunity.
    Rambach G; Würzner R; Speth C
    Contrib Microbiol; 2008; 15():78-100. PubMed ID: 18511857
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The C5a receptor of neutrophils and macrophages.
    Chenoweth DE; Goodman MG
    Agents Actions Suppl; 1983; 12():252-73. PubMed ID: 6573117
    [No Abstract]   [Full Text] [Related]  

  • 31. Voluntary-Opsonization-Enabled Precision Nanomedicines for Inflammation Treatment.
    Li S; Li M; Huo S; Wang Q; Chen J; Ding S; Zeng Z; Zhou W; Wang Y; Wang J
    Adv Mater; 2021 Jan; 33(3):e2006160. PubMed ID: 33296121
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Modern determination of complement activation.
    Oppermann M; Würzner R
    Semin Thromb Hemost; 2010 Sep; 36(6):611-9. PubMed ID: 20865637
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [The terminal complement complex (TCC)--a mediator in the development of disease in man?].
    Garred P
    Ugeskr Laeger; 1991 Jan; 153(5):351-3. PubMed ID: 1994560
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Natural immunostimulants].
    Nikitin AV; Navashin SM
    Antibiotiki; 1983 Sep; 28(9):702-16. PubMed ID: 6357066
    [No Abstract]   [Full Text] [Related]  

  • 35. Immunomodulators and the complement system.
    Kondo M; Kato H; Yoshikawa T; Sugino S
    Methods Find Exp Clin Pharmacol; 1986 Feb; 8(2):67-72. PubMed ID: 3713376
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Cellular receptors for complement components: repertory and functions].
    Sobel A; Blanc C; Cattaneo A; Moisy M; Lopez-Trascasa M
    Ann Immunol (Paris); 1982; 133C(2):199-205. PubMed ID: 7051951
    [No Abstract]   [Full Text] [Related]  

  • 37. Inhibition of complement-mediated functions of human neutrophils by impermeant stilbene disulfonic acids.
    Tauber AI; Goetzl EJ
    J Immunol; 1981 May; 126(5):1786-9. PubMed ID: 6260856
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The behaviour of phagocytic cell receptors in relation to allergic red cell destruction.
    Brown DL
    Ser Haematol; 1974; 7(3):348-57. PubMed ID: 4610756
    [No Abstract]   [Full Text] [Related]  

  • 39. Selective inhibition of IgG-mediated phagocytosis in gelsolin-deficient murine neutrophils.
    Serrander L; Skarman P; Rasmussen B; Witke W; Lew DP; Krause KH; Stendahl O; Nüsse O
    J Immunol; 2000 Sep; 165(5):2451-7. PubMed ID: 10946270
    [TBL] [Abstract][Full Text] [Related]  

  • 40. CRIg: a macrophage complement receptor required for phagocytosis of circulating pathogens.
    Helmy KY; Katschke KJ; Gorgani NN; Kljavin NM; Elliott JM; Diehl L; Scales SJ; Ghilardi N; van Lookeren Campagne M
    Cell; 2006 Mar; 124(5):915-27. PubMed ID: 16530040
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.